Breaking Corporate Events, Analysed in Real Time

UPL Ltd Reports 11% Revenue Growth in FY26 as PATMI More Than Doubles

UPL Ltd exceeded its annual guidance for FY26, reporting an 11% increase in revenue and a significant recovery in net profitability. The company achieved its deleveraging goals by reducing gross debt by $850 million, supported by strong volume growth across its global platforms.

Emcure Pharmaceuticals Achieves ₹9,204 Cr Revenue Milestone; Targets Margin Growth in FY27

Emcure Pharmaceuticals surpassed the $1 billion revenue milestone in FY26, driven by a 22.2% surge in international markets. While domestic restructuring led to a temporary Q4 slowdown in the Zuventus portfolio, management has guided for margin expansion and steady growth for FY27.